Disc Medicine Inc’s filing revealed that its Chief Financial Officer Franchi Jean M. unloaded Company’s shares for reported $0.1 million on Jun 16 ’25. In the deal valued at $52.26 per share,2,000 shares were sold. As a result of this transaction, Franchi Jean M. now holds 67,530 shares worth roughly $3.45 million.
Then, JEAN FRANCHI bought 2,000 shares, generating $107,420 in total proceeds.
Before that, Savage William Jacob sold 2,996 shares. Disc Medicine Inc shares valued at $149,800 were divested by the Chief Medical Officer at a price of $50.00 per share. As a result of the transaction, Savage William Jacob now holds 56,725 shares, worth roughly $2.9 million.
A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in late February with a ‘”a Buy”‘ rating. Morgan Stanley also remained covering IRON and has increased its forecast on November 05, 2024 with a “an Overweight” recommendation from previously “an Equal-weight” rating. Raymond James revised its rating on November 04, 2024. It rated IRON as “a Strong buy” which previously was an “an Outperform”.
Price Performance Review of IRON
On Tuesday, Disc Medicine Inc [NASDAQ:IRON] saw its stock fall -3.46% to $51.13. Over the last five days, the stock has lost -7.04%. Disc Medicine Inc shares have risen nearly 15.29% since the year began. Nevertheless, the stocks have fallen -19.35% over the past one year. While a 52-week high of $68.73 was reached on 01/02/25, a 52-week low of $30.82 was recorded on 04/09/25.
Levels Of Support And Resistance For IRON Stock
The 24-hour chart illustrates a support level at 50.21, which if violated will result in even more drops to 49.29. On the upside, there is a resistance level at 52.85. A further resistance level may holdings at 54.57.
How much short interest is there in Disc Medicine Inc?
A steep rise in short interest was recorded in Disc Medicine Inc stocks on 2025-06-13, dropping by 26633.0 shares to a total of 3.2 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 3.23 million shares. There was a decline of -0.83%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on October 23, 2024 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $89 price target.
